{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T17:28:30Z","timestamp":1778261310498,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007225","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["107-2314-B-002-245"],"award-info":[{"award-number":["107-2314-B-002-245"]}],"id":[{"id":"10.13039\/100007225","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.ijantimicag.2019.10.001","type":"journal-article","created":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T01:59:10Z","timestamp":1571018350000},"page":"105820","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Anidulafungin as an alternative treatment for Pneumocystis jirovecii pneumonia in patients who cannot tolerate trimethoprim\/sulfamethoxazole"],"prefix":"10.1016","volume":"55","author":[{"given":"Po-Yi","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong-Jen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Yien","family":"Chien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7502-9225","authenticated-orcid":false,"given":"Po-Ren","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2019.10.001_bib0001","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMra032588","article-title":"Pneumocystis pneumonia","volume":"350","author":"Thomas","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2019.10.001_bib0002","doi-asserted-by":"crossref","unstructured":"Kovacs J.A., Hiemenz J.W., Macher A.M., Stover D., Murray H.W., Shelhamer J., et al. Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med 1984;100:663\u201371.","DOI":"10.7326\/0003-4819-100-5-663"},{"key":"10.1016\/j.ijantimicag.2019.10.001_bib0003","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jmii.2018.11.001","article-title":"Coinfection of Pneumocystis jiroveci pneumonia and pulmonary aspergillosis in a non-HIV-infected patient","volume":"51","author":"Lee","year":"2018","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijantimicag.2019.10.001_bib0004","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.jmii.2016.06.006","article-title":"Pneumocystis pneumonia associated with peripheral lymphocytosis in angioimmunoblastic T-cell lymphoma, resembling immune reconstitution syndrome","volume":"50","author":"Tabata","year":"2017","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijantimicag.2019.10.001_bib0005","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jmii.2012.08.024","article-title":"Pneumocystis jiroveci pneumonia in immunocompromised patients: delayed diagnosis and poor outcomes in non-HIV-infected individuals","volume":"47","author":"Li","year":"2014","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijantimicag.2019.10.001_bib0006","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jmii.2017.07.007","article-title":"Low-dose trimethoprim\u2013sulfamethoxazole treatment for pneumocystis pneumonia in non-human immunodeficiency virus-infected immunocompromised patients: a single-center retrospective observational cohort study","volume":"51","author":"Nakashima","year":"2018","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijantimicag.2019.10.001_bib0007","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1164\/rccm.2008-740ST","article-title":"An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients","volume":"183","author":"Limper","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2019.10.001_bib0008","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2165\/00002018-199410060-00003","article-title":"Adverse effects of drugs used in the management of opportunistic infections associated with HIV infection","volume":"10","author":"Peters","year":"1994","journal-title":"Drug Saf"},{"key":"10.1016\/j.ijantimicag.2019.10.001_bib0009","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1128\/cdli.1.5.511-516.1994","article-title":"Comparison of corticosteroid- and L3T4+ antibody-immunosuppressed mouse models of Pneumocystis carinii pneumonia for evaluation of drugs and leukocytes","volume":"1","author":"Bartlett","year":"1994","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.ijantimicag.2019.10.001_bib0010","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1128\/AAC.40.8.1811","article-title":"Semisynthetic echinocandins affect cell wall deposition of Pneumocystis carinii in vitro and in vivo","volume":"40","author":"Bartlett","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.10.001_bib0011","doi-asserted-by":"crossref","first-page":"53S","DOI":"10.1111\/j.1550-7408.1997.tb05774.x","article-title":"Therapeutic effect of a water-soluble echinocandin compound on Pneumocystis pneumonia in animals","volume":"44","author":"Furuta","year":"1997","journal-title":"J Eukaryot Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.10.001_bib0012","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1128\/AAC.42.8.1985","article-title":"Efficacy of MK-991 (L-743,872), a semisynthetic pneumocandin, in murine models of Pneumocystis carinii","volume":"42","author":"Powles","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.10.001_bib0013","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1128\/AAC.44.9.2259-2262.2000","article-title":"Prophylactic effect of FK463, a novel antifungal lipopeptide, against Pneumocystis carinii infection in mice","volume":"44","author":"Ito","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.10.001_bib0014","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jac\/dkg117","article-title":"Caspofungin: the first representative of a new antifungal class","volume":"51","author":"Letscher-Bru","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.10.001_bib0015","doi-asserted-by":"crossref","first-page":"e8524","DOI":"10.1371\/journal.pone.0008524","article-title":"Echinocandin treatment of pneumocystis pneumonia in rodent models depletes cysts leaving trophic burdens that cannot transmit the infection","volume":"5","author":"Cushion","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2019.10.001_bib0016","doi-asserted-by":"crossref","first-page":"4513","DOI":"10.1128\/AAC.00017-11","article-title":"Susceptibility of Pneumocystis to echinocandins in suspension and biofilm cultures","volume":"55","author":"Cushion","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.10.001_bib0017","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/01.tp.0000280546.91617.6c","article-title":"Efficacy of caspofungin addition to trimethoprim\u2013sulfamethoxazole treatment for severe pneumocystis pneumonia in solid organ transplant recipients","volume":"84","author":"Utili","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.ijantimicag.2019.10.001_bib0018","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s10096-005-0065-z","article-title":"Caspofungin treatment of Pneumocystis pneumonia during conditioning for bone marrow transplantation","volume":"25","author":"Annaloro","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.ijantimicag.2019.10.001_bib0019","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1439-0507.2008.01530.x","article-title":"Pneumocystis jiroveci pneumonia in a patient with Wegener's granulomatosis treated efficiently with caspofungin","volume":"51","author":"Hof","year":"2008","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2019.10.001_bib0020","first-page":"996","article-title":"Caspofungin in salvage treatment of severe pneumocystis pneumonia: case report and literature review","volume":"122","author":"Mu","year":"2009","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.ijantimicag.2019.10.001_bib0021","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/thx.2010.135350","article-title":"A trial of caspofungin salvage treatment in PCP pneumonia","volume":"66","author":"Armstrong-James","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.ijantimicag.2019.10.001_bib0022","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1073\/pnas.87.15.5950","article-title":"Treatment of Pneumocystis carinii pneumonia with 1,3-\u03b2-glucan synthesis inhibitors","volume":"87","author":"Schmatz","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijantimicag.2019.10.001_bib0023","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1086\/505204","article-title":"Anidulafungin: a novel echinocandin","volume":"43","author":"Vazquez","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.10.001_bib0024","first-page":"6S","article-title":"Yeast glucan of Pneumocystis carinii cyst wall: an excellent target for chemotherapy","volume":"38","author":"Matsumoto","year":"1991","journal-title":"J Protozool"},{"key":"10.1016\/j.ijantimicag.2019.10.001_bib0025","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/mmy\/myu060","article-title":"Efficacy of caspofungin, a 1,3-\u03b2-d-glucan synthase inhibitor, on Pneumocystis carinii pneumonia in rats","volume":"52","author":"Sun","year":"2014","journal-title":"Med Mycol"},{"key":"10.1016\/j.ijantimicag.2019.10.001_bib0026","first-page":"E162","article-title":"Pneumocystis jiroveci pneumonia in patients with non-Hodgkin's lymphoma after rituximab-containing regimen: two cases of report and literature review","volume":"5","author":"Jiang","year":"2013","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.ijantimicag.2019.10.001_bib0027","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jmii.2016.03.008","article-title":"Caspofungin salvage therapy in Pneumocystis jirovecii pneumonia","volume":"50","author":"Lee","year":"2017","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijantimicag.2019.10.001_bib0028","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1097\/QAD.0000000000002207","article-title":"Echinocandins as alternative treatment for HIV-infected patients with Pneumocystis pneumonia","volume":"33","author":"Huang","year":"2019","journal-title":"AIDS"},{"key":"10.1016\/j.ijantimicag.2019.10.001_bib0029","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/10408379991249194","article-title":"Imaging features of Pneumocystis carinii pneumonia","volume":"40","author":"Crans","year":"1999","journal-title":"Crit Rev Diagn Imaging"},{"key":"10.1016\/j.ijantimicag.2019.10.001_bib0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2217\/fmb-2016-0115","article-title":"Evaluation of the automated Becton Dickinson MAX real-time PCR platform for detection of Pneumocystis jirovecii","volume":"12","author":"Chien","year":"2017","journal-title":"Future Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.10.001_bib0031","doi-asserted-by":"crossref","first-page":"e70619","DOI":"10.1371\/journal.pone.0070619","article-title":"Therapeutic potential of caspofungin combined with trimethoprim\u2013sulfamethoxazole for Pneumocystis pneumonia: a pilot study in mice","volume":"8","author":"Lobo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2019.10.001_bib0032","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3109\/00365548.2012.760842","article-title":"Is caspofungin really an effective treatment for Pneumocystis jirovecii pneumonia in immunocompromised patients without human immunodeficiency virus infection? Experiences at a single center and a literature review","volume":"45","author":"Kim","year":"2013","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.10.001_bib0033","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.transproceed.2017.04.020","article-title":"Combination of echinocandins and trimethoprim\/sulfamethoxazole for the treatment of Pneumocystis jiroveci pneumonia after heart transplantation","volume":"49","author":"Lu","year":"2017","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ijantimicag.2019.10.001_bib0034","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1093\/jac\/dkw155","article-title":"Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients","volume":"71","author":"Cordonnier","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.10.001_bib0035","article-title":"Pneumocystis pneumonia in patients with autoimmune diseases: a retrospective study focused on clinical characteristics and prognostic factors related to death","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2019.10.001_bib0036","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206231","article-title":"Pneumocystis jirovecii pneumonia (PCP) PCR-negative conversion predicts prognosis of HIV-negative patients with PCP and acute respiratory failure","volume":"13","author":"Choi","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2019.10.001_bib0037","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/cc6806","article-title":"Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection","volume":"12","author":"Monnet","year":"2008","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2019.10.001_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmii.2019.05.003","article-title":"Pneumocystis jiroveci pneumonia in Taiwan from 2014 to 2017: clinical manifestations and outcomes between pediatric and adult patients","author":"Lee","year":"2019","journal-title":"J Microbiol Immunol Infect"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919302754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919302754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:36:04Z","timestamp":1760376964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857919302754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0924857919302754"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.10.001","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anidulafungin as an alternative treatment for Pneumocystis jirovecii pneumonia in patients who cannot tolerate trimethoprim\/sulfamethoxazole","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105820"}}